Contact Us
Biomarker Discovery Outsourcing Services Global Market Report 2025
Global Biomarker Discovery Outsourcing Services Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Biomarker Discovery Outsourcing Services Global Market Report 2025

By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints), By Discovery Phase (Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection), By Therapeutic Area (Oncology, Cardiology, Neurology, Autoimmune Diseases, Other Therapeutic Areas), By End Use (Pharmaceutical Companies, Biotechnology Companies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biomarker Discovery Outsourcing Services Market Overview

• Biomarker Discovery Outsourcing Services market size has reached to $14.58 billion in 2024

• Expected to grow to $30.13 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%

• Growth Driver: Personalized Medicine Driving Growth In Biomarker Discovery Outsourcing

• Market Trend: Advanced Technologies Driving Innovation In The Biomarker Discovery Outsourcing Services Market

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biomarker Discovery Outsourcing Services Market?

Biomarker discovery outsourcing services refer to specialized services provided by external organizations or companies that assist in identifying, validating, and developing biomarkers. These services facilitate the advancement of personalized medicine by enabling the identification of biological markers that can guide diagnosis, prognosis, and therapeutic decisions tailored to individual patients.

The main types of biomarker discovery outsourcing services are predictive biomarkers, prognostic biomarkers, safety biomarkers, and surrogate endpoints. Predictive biomarkers are biological indicators used to identify which patients are likely to benefit from a specific therapeutic intervention. The discovery phases are categorized into biomarker identification, biomarker validation, biomarker profiling, biomarker panel development, and biomarker selection used for therapeutic areas such as Oncology, cardiology, neurology, autoimmune diseases, and others. End users, such as pharmaceutical companies and biotechnology companies.

Biomarker Discovery Outsourcing Services Market Size and growth rate 2025 to 2029: Graph

What Is The Biomarker Discovery Outsourcing Services Market Size 2025 And Growth Rate?

The biomarker discovery outsourcing services market size has grown rapidly in recent years. It will grow from $14.58 billion in 2024 to $16.96 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing disease burden, pharmaceutical R&D demand, the regulatory environment, cost-effective solutions, research collaboration, and globalization.

What Is The Biomarker Discovery Outsourcing Services Market Growth Forecast?

The biomarker discovery outsourcing services market size is expected to see rapid growth in the next few years. It will grow to $30.13 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to personalized medicine expansion, AI and machine learning integration, precision oncology growth, biomarker validation services, regulatory support, targeted therapy demand, and patient-centric healthcare. Major trends in the forecast period include increased adoption of precision medicine, technological advancements, rising demand for companion diagnostics, expansion of drug development pipelines, emerging applications in non-traditional disease areas, integration of artificial intelligence (AI) and machine learning (ML), regulatory support and standardization, global market expansion, partnerships and collaborations, and a and a focus on cost-effectiveness and time efficiency.

The forecast of 15.4% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. precision medicine by restricting access to proteomic analysis and multi-omics platforms imported from Sweden and Denmark, potentially slowing biomarker identification and increasing research costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Biomarker Discovery Outsourcing Services Market Segmented?

1) By Type: Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints

2) By Discovery Phase: Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection

3) By Therapeutic Area: Oncology, Cardiology, Neurology, Autoimmune Diseases, Other Therapeutic Areas

4) By End Use: Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Predictive Biomarkers: Disease Risk Assessment, Therapy Response Prediction, Personalized Medicine Guidance

2) By Prognostic Biomarkers: Disease Progression Prediction, Patient Survival Forecast, Recurrence Risk Assessment

3) By Safety Biomarkers: Toxicity Prediction, Drug Safety Evaluation, Adverse Effect Risk Assessment

4) By Surrogate Endpoints: Clinical Trial Outcome Indicators, Disease Progression Monitoring, Therapy Efficacy Tracking

What Is Driving The Biomarker Discovery Outsourcing Services Market? Personalized Medicine Driving Growth In Biomarker Discovery Outsourcing

The rising focus on personalized medicine is expected to propel the growth of the biomarker discovery outsourcing services market going forward. Personalized medicine refers to healthcare that tailors medical treatment to the individual characteristics of each patient. The rise of personalized medicine is due to individual genetic, lifestyle, and environmental factors, resulting in precise healthcare outcomes that ultimately improve patient care and reduce adverse effects. Outsourcing biomarker discovery services facilitates the advancement of personalized medicine by providing tailored diagnostic and therapeutic solutions based on individual patients' biological markers. For instance, in February 2024, according to a report published by the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing focus on personalized medicine drives the growth of the biomarker discovery outsourcing services.

Who Are The Major Players In The Global Biomarker Discovery Outsourcing Services Market?

Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.

What Are The Key Trends Of The Global Biomarker Discovery Outsourcing Services Market? Advanced Technologies Driving Innovation In The Biomarker Discovery Outsourcing Services Market

Major companies operating in the biomarker discovery outsourcing services market are focusing on developing multiplexed biomarker assays, such as the immunoproteomic discovery platform, to improve patient outcomes and advance the field of discovering biomarkers. An immunoproteomic discovery platform is a specialized system that combines immunology and proteomics to identify and analyze proteins related to the immune response. For instance, in October 2023, Sengenics Corporation LLC, a Singapore-based precision medicine company, launched the immunoproteomic discovery platform, a comprehensive protein microarray platform for analyzing autoantibodies associated with disease diagnosis and therapeutic intervention. The i-Ome Discovery platform was developed to advance immune biomarker discovery and development and support academic and clinical biopharmaceutical research teams seeking to better understand the dynamic interactions and relationships between proteins, the immune system, and disease.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Biomarker Discovery Outsourcing Services Market? Fujirebio Holdings Acquires ADx NeuroSciences To Enhance Neurological Diagnostics

In August 2022, Fujirebio Holdings Inc., a Japan-based company specializes in diagnostics, acquired ADx NeuroSciences for $44 million. Through this acquisition, Fujirebio aims to expand its portfolio of in vitro diagnostics and leverage expertise in biomarker development to accelerate innovations in neurological testing. ADx NeuroSciences a Belgium-based company specializes in biomarkers duiscoervy assay and outsourcing services.

What Is The Regional Outlook For The Global Biomarker Discovery Outsourcing Services Market?

North America was the largest region in the biomarker discovery outsourcing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Biomarker Discovery Outsourcing Services Market?

The biomarker discovery outsourcing services market includes revenues earned by entities through validation and verification studies, clinical sample analysis, bioinformatics, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biomarker Discovery Outsourcing Services Industry?

The biomarker discovery outsourcing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biomarker discovery outsourcing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biomarker Discovery Outsourcing Services Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $16.96 billion
Revenue Forecast In 2034 $30.13 billion
Growth Rate CAGR of 15.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints
2) By Discovery Phase: Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection
3) By Therapeutic Area: Oncology, Cardiology, Neurology, Autoimmune Diseases, Other Therapeutic Areas
4) By End Use: Pharmaceutical Companies, Biotechnology Companies Subsegments: 1) By Predictive Biomarkers: Disease Risk Assessment, Therapy Response Prediction, Personalized Medicine Guidance
2) By Prognostic Biomarkers: Disease Progression Prediction, Patient Survival Forecast, Recurrence Risk Assessment
3) By Safety Biomarkers: Toxicity Prediction, Drug Safety Evaluation, Adverse Effect Risk Assessment
4) By Surrogate Endpoints: Clinical Trial Outcome Indicators, Disease Progression Monitoring, Therapy Efficacy Tracking
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biomarker Discovery Outsourcing Services Market Characteristics

3. Biomarker Discovery Outsourcing Services Market Trends And Strategies

4. Biomarker Discovery Outsourcing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biomarker Discovery Outsourcing Services Growth Analysis And Strategic Analysis Framework

5.1. Global Biomarker Discovery Outsourcing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biomarker Discovery Outsourcing Services Market Growth Rate Analysis

5.4. Global Biomarker Discovery Outsourcing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biomarker Discovery Outsourcing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biomarker Discovery Outsourcing Services Total Addressable Market (TAM)

6. Biomarker Discovery Outsourcing Services Market Segmentation

6.1. Global Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Predictive Biomarkers

Prognostic Biomarkers

Safety Biomarkers

Surrogate Endpoints

6.2. Global Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biomarker Identification

Biomarker Validation

Biomarker Profiling

Biomarker Panel Development

Biomarker Selection

6.3. Global Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Cardiology

Neurology

Autoimmune Diseases

Other Therapeutic Areas

6.4. Global Biomarker Discovery Outsourcing Services Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotechnology Companies

6.5. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Disease Risk Assessment

Therapy Response Prediction

Personalized Medicine Guidance

6.6. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Disease Progression Prediction

Patient Survival Forecast

Recurrence Risk Assessment

6.7. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Toxicity Prediction

Drug Safety Evaluation

Adverse Effect Risk Assessment

6.8. Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Surrogate Endpoints, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Trial Outcome Indicators

Disease Progression Monitoring

Therapy Efficacy Tracking

7. Biomarker Discovery Outsourcing Services Market Regional And Country Analysis

7.1. Global Biomarker Discovery Outsourcing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biomarker Discovery Outsourcing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biomarker Discovery Outsourcing Services Market

8.1. Asia-Pacific Biomarker Discovery Outsourcing Services Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biomarker Discovery Outsourcing Services Market

9.1. China Biomarker Discovery Outsourcing Services Market Overview

9.2. China Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biomarker Discovery Outsourcing Services Market

10.1. India Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biomarker Discovery Outsourcing Services Market

11.1. Japan Biomarker Discovery Outsourcing Services Market Overview

11.2. Japan Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biomarker Discovery Outsourcing Services Market

12.1. Australia Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biomarker Discovery Outsourcing Services Market

13.1. Indonesia Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biomarker Discovery Outsourcing Services Market

14.1. South Korea Biomarker Discovery Outsourcing Services Market Overview

14.2. South Korea Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biomarker Discovery Outsourcing Services Market

15.1. Western Europe Biomarker Discovery Outsourcing Services Market Overview

15.2. Western Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biomarker Discovery Outsourcing Services Market

16.1. UK Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biomarker Discovery Outsourcing Services Market

17.1. Germany Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biomarker Discovery Outsourcing Services Market

18.1. France Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biomarker Discovery Outsourcing Services Market

19.1. Italy Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biomarker Discovery Outsourcing Services Market

20.1. Spain Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biomarker Discovery Outsourcing Services Market

21.1. Eastern Europe Biomarker Discovery Outsourcing Services Market Overview

21.2. Eastern Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biomarker Discovery Outsourcing Services Market

22.1. Russia Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biomarker Discovery Outsourcing Services Market

23.1. North America Biomarker Discovery Outsourcing Services Market Overview

23.2. North America Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biomarker Discovery Outsourcing Services Market

24.1. USA Biomarker Discovery Outsourcing Services Market Overview

24.2. USA Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biomarker Discovery Outsourcing Services Market

25.1. Canada Biomarker Discovery Outsourcing Services Market Overview

25.2. Canada Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biomarker Discovery Outsourcing Services Market

26.1. South America Biomarker Discovery Outsourcing Services Market Overview

26.2. South America Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biomarker Discovery Outsourcing Services Market

27.1. Brazil Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biomarker Discovery Outsourcing Services Market

28.1. Middle East Biomarker Discovery Outsourcing Services Market Overview

28.2. Middle East Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biomarker Discovery Outsourcing Services Market

29.1. Africa Biomarker Discovery Outsourcing Services Market Overview

29.2. Africa Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biomarker Discovery Outsourcing Services Market Competitive Landscape And Company Profiles

30.1. Biomarker Discovery Outsourcing Services Market Competitive Landscape

30.2. Biomarker Discovery Outsourcing Services Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Labcorp Drug Development Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. ICON plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.5. WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Biomarker Discovery Outsourcing Services Market Other Major And Innovative Companies

31.1. Syneos Health Inc.

31.2. Intertek Group plc

31.3. Charles River Laboratories International Inc.

31.4. Parexel International Corporation

31.5. QIAGEN N.V.

31.6. Medpace Inc.

31.7. Bioclinica Inc.

31.8. Evotec SE

31.9. GenScript Biotech Corporation

31.10. Precision for Medicine Inc.

31.11. BioAgilytix Labs LLC

31.12. Celerion Inc.

31.13. Frontage Laboratories Inc.

31.14. SomaLogic Inc.

31.15. Selvita S.A.

32. Global Biomarker Discovery Outsourcing Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomarker Discovery Outsourcing Services Market

34. Recent Developments In The Biomarker Discovery Outsourcing Services Market

35. Biomarker Discovery Outsourcing Services Market High Potential Countries, Segments and Strategies

35.1 Biomarker Discovery Outsourcing Services Market In 2029 - Countries Offering Most New Opportunities

35.2 Biomarker Discovery Outsourcing Services Market In 2029 - Segments Offering Most New Opportunities

35.3 Biomarker Discovery Outsourcing Services Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biomarker Discovery Outsourcing Services Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Surrogate Endpoints, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Biomarker Discovery Outsourcing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Biomarker Discovery Outsourcing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Labcorp Drug Development Inc. Financial Performance
  • Table 81: ICON plc Financial Performance
  • Table 82: Eurofins Scientific SE Financial Performance
  • Table 83: WuXi AppTec Co. Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biomarker Discovery Outsourcing Services Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Biomarker Discovery Outsourcing Services Market, Sub-Segmentation Of Surrogate Endpoints, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Biomarker Discovery Outsourcing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Biomarker Discovery Outsourcing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Biomarker Discovery Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Biomarker Discovery Outsourcing Services Market, Segmentation By Discovery Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Biomarker Discovery Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Labcorp Drug Development Inc. Financial Performance
  • Figure 81: ICON plc Financial Performance
  • Figure 82: Eurofins Scientific SE Financial Performance
  • Figure 83: WuXi AppTec Co. Ltd. Financial Performance

Frequently Asked Questions

Biomarker discovery outsourcing services refer to specialized services provided by external organizations or companies that assist in identifying, validating, and developing biomarkers. These services facilitate the advancement of personalized medicine by enabling the identification of biological markers that can guide diagnosis, prognosis, and therapeutic decisions tailored to individual patients. For further insights on this market, request a sample here

The market major growth driver - Personalized Medicine Driving Growth In Biomarker Discovery Outsourcing. For further insights on this market, request a sample here

The biomarker discovery outsourcing services market size has grown rapidly in recent years. It will grow from $14.58 billion in 2024 to $16.96 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing disease burden, pharmaceutical R&D demand, the regulatory environment, cost-effective solutions, research collaboration, and globalization. The biomarker discovery outsourcing services market size is expected to see rapid growth in the next few years. It will grow to " $30.13 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to personalized medicine expansion, AI and machine learning integration, precision oncology growth, biomarker validation services, regulatory support, targeted therapy demand, and patient-centric healthcare. Major trends in the forecast period include increased adoption of precision medicine, technological advancements, rising demand for companion diagnostics, expansion of drug development pipelines, emerging applications in non-traditional disease areas, integration of artificial intelligence (AI) and machine learning (ML), regulatory support and standardization, global market expansion, partnerships and collaborations, and a and a focus on cost-effectiveness and time efficiency. For further insights on this market, request a sample here

The biomarker discovery outsourcing servicesmarket covered in this report is segmented –
1) By Type: Predictive Biomarkers; Prognostic Biomarkers; Safety Biomarkers; Surrogate Endpoints
2) By Discovery Phase: Biomarker Identification; Biomarker Validation; Biomarker Profiling; Biomarker Panel Development; Biomarker Selection
3) By Therapeutic Area: Oncology; Cardiology; Neurology; Autoimmune Diseases; Other Therapeutic Areas
4) By End Use: Pharmaceutical Companies; Biotechnology Companies Subsegments:
1) By Predictive Biomarkers: Disease Risk Assessment; Therapy Response Prediction; Personalized Medicine Guidance
2) By Prognostic Biomarkers: Disease Progression Prediction; Patient Survival Forecast; Recurrence Risk Assessment
3) By Safety Biomarkers: Toxicity Prediction; Drug Safety Evaluation; Adverse Effect Risk Assessment
4) By Surrogate Endpoints: Clinical Trial Outcome Indicators; Disease Progression Monitoring; Therapy Efficacy Tracking For further insights on this market,
request a sample here

North America was the largest region in the biomarker discovery outsourcing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.. For further insights on this market, request a sample here.

Major trends in this market include Advanced Technologies Driving Innovation In The Biomarker Discovery Outsourcing Services Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon